Report Library
All Reports
2015 Post-Report: Future of Genomic Medicine VIII
March 17, 2015
The Future of Genomic Medicine VIII course took place on March 5–6, 2015 in San Diego, California. This course was directed by Dr.
Eric Topol from the Scripps Translational Research Institute (STRI) and developed in collaboration with Science Translational Medicine,
a journal published by the American Association for the Advancement of Science (AAAS). Key topics discussed at this meeting included
the following:
For the full report, please download the PDF version at the top of this page.
For our disclosures, please read the BioMedTracker Research Standards.
- The Precision Medicine Initiative has the potential to generate data correlating genetics, lifestyle, and clinical outcomes for a cross- section of Americans. Drug sponsors will be able to mine any public information generated to seek drug targets or diagnostic biomarkers.
- Increased uptake of non-invasive prenatal testing (NIPT) has reduced rates of invasive procedures in pregnant women at elevated risk for chromosomal abnormalities.
- Other “liquid biopsy” techniques have the potential to non-invasively monitor tumor mutations or risk of the heart attacks.
- Although the human microbiome certainly plays a major role in disease and immunity, the current level of scientific understanding of these interactions is limited and may only generate near-term clinical gains in severe gastrointestinal disorders.
For the full report, please download the PDF version at the top of this page.
For our disclosures, please read the BioMedTracker Research Standards.
Disease Group Covered: |
Infectious Disease
Obstetrics/Gynecology Oncology |
Indications Covered: | Castleman's Disease |
Additional Resources: